The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood
Open accessAbstract
Individuals carrying (GGGGCC) expanded repeats in the C9orf72 gene represent a significant portion of patients suffering from amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Elucidating how these expanded repeats cause "c9FTD/ALS" has since become an important goal of the field. Toward this end, we sought to investigate whether epigenetic changes are responsible for the decrease in C9orf72 expression levels observed in c9FTD/ALS patients. We obtained brain tissue from ten c9FTD/ALS individuals, nine FTD/ALS cases without a C9orf72 repeat expansion, and nine disease control participants, and generated fibroblastoid cell lines from seven C9orf72 expanded repeat carriers and seven participants carrying normal alleles. Chromatin immunoprecipitation using antibodies for histone H3 and H4 trimethylated at lysines 9 (H3K9), 27 (H3K27), 79 (H3K79), and 20 (H4K20) revealed that these trimethylated residues bind strongly to C9orf72 expanded repeats in brain tissue, but not to non-pathogenic repeats. Our finding that C9orf72 mRNA levels are reduced in the frontal cortices and cerebella of c9FTD/ALS patients is consistent with trimethylation of these histone residues, an event known to repress gene expression. Moreover, treating repeat carrier-derived fibroblasts with 5-aza-2-deoxycytidine, a DNA and histone demethylating agent, not only decreased C9orf72 binding to trimethylated histone residues, but also increased C9orf72 mRNA expression. Our results provide compelling evidence that trimethylation of lysine residues within histones H3 and H4 is a novel mechanism involved in reducing C9orf72 mRNA expression in expanded repeat carriers. Of importance, we show that mutant C9orf72 binding to trimethylated H3K9 and H3K27 is detectable in blood of c9FTD/ALS patients. Confirming these exciting results using blood from a larger cohort of patients may establish this novel epigenetic event as a biomarker for c9FTD/ALS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High-Resolution Profiling of Histone Methylations in the Human Genome
Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I., & Zhao, K. (2007) · Cell · doi:10.1016/j.cell.2007.05.009 · Cited by 6,845 · cited 1×
“We next explored whether this decrease in C9orf72 expression results from aberrant histone methylation, given that trimethylation of histone H3 at lysines 9, 27, 79, as well as of histone H4 at lysine 20, is linked to gene repression [3].”
BackgroundDeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
Self-citationA Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
The Free Radical Theory of Aging Matures
BECKMAN, K. B., & AMES, B. N. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.2.547 · Cited by 3,879
CpG Islands in vertebrate genomes
Gardiner-Garden, M., & Frommer, M. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90689-9 · Cited by 3,353
Stadtman, E. R. (1992) · Science · doi:10.1126/science.1355616 · Cited by 2,697
Linking DNA methylation and histone modification: patterns and paradigms
Cedar, H., & Bergman, Y. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2540 · Cited by 2,267
Absolute quantification by droplet digital PCR versus analog real-time PCR
Hindson, C. M., Chevillet, J. R., Briggs, H. A., Gallichotte, E. N., Ruf, I. K., Hindson, B. J., Vessella, R. L., & Tewari, M. (2013) · Nature Methods · doi:10.1038/nmeth.2633 · Cited by 1,488
The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS
Mori, K., Weng, S.-M., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H. A., Cruts, M., Van Broeckhoven, C., et al. (2013) · Science · doi:10.1126/science.1232927 · Cited by 1,277
Ash, P. E. A., Bieniek, K. F., Gendron, T. F., Caulfield, T., Lin, W.-L., DeJesus-Hernandez, M., van Blitterswijk, M. M., Jansen-West, K., Paul, J. W., Rademakers, R., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.004 · Cited by 1,100
Self-citationStadtman, E. R. (2006) · Free Radical Research · doi:10.1080/10715760600918142 · Cited by 1,056
Neurology in Clinical Practice
Bradley, G. W. (2004) · Medical Entomology and Zoology · Cited by 746
The overlap of amyotrophic lateral sclerosis and frontotemporal dementia
Lomen-Hoerth, C., Anderson, T., & Miller, B. (2002) · Neurology · doi:10.1212/wnl.59.7.1077 · Cited by 699
Epigenetics and aging: the targets and the marks
Fraga, M. F., & Esteller, M. (2007) · Trends in Genetics · doi:10.1016/j.tig.2007.05.008 · Cited by 690
Gijselinck, I., Van Langenhove, T., van der Zee, J., Sleegers, K., Philtjens, S., Kleinberger, G., Janssens, J., Bettens, K., Van Cauwenberghe, C., Pereson, S., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70261-7 · Cited by 633
Molecular Mechanisms of Fragile X Syndrome: A Twenty-Year Perspective
Santoro, M. R., Bray, S. M., & Warren, S. T. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132457 · Cited by 528 · cited 1×
“given that methylation of repeat sequences, as well as hypermethylation of adjacent Cpg islands within promoter regions, has been shown to aberrantly influence histone methylation processes leading to gene silencing and consequently loss of protein function [1, 37], we sought to determine whether a similar disease cas…”
BackgroundEpigenetic Regulation of Motor Neuron Cell Death through DNA Methylation
Chestnut, B. A., Chang, Q., Price, A., Lesuisse, C., Wong, M., & Martin, L. J. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.1639-11.2011 · Cited by 362
Mori, K., Lammich, S., Mackenzie, I. R. A., Forné, I., Zilow, S., Kretzschmar, H., Edbauer, D., Janssens, J., Kleinberger, G., Cruts, M., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1088-7 · Cited by 342
Neurology in Clinical Practice
Matsumoto, J. Y. (1992) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60814-3 · Cited by 340
Ciura, S., Lattante, S., Le Ber, I., Latouche, M., Tostivint, H., Brice, A., & Kabashi, E. (2013) · Annals of Neurology · doi:10.1002/ana.23946 · Cited by 333
Genetics of amyotrophic lateral sclerosis: an update
Chen, S., Sayana, P., Zhang, X., & Le, W. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-28 · Cited by 326
Immune-mediated Mechanisms in the Pathoprogression of Amyotrophic Lateral Sclerosis
Zhao, W., Beers, D. R., & Appel, S. H. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9489-x · Cited by 300
Hypermethylation of the CpG Island Near the G4C2 Repeat in ALS with a C9orf72 Expansion
Xi, Z., Zinman, L., Moreno, D., Schymick, J., Liang, Y., Sato, C., Zheng, Y., Ghani, M., Dib, S., Keith, J., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.04.017 · Cited by 266
Al-Mahdawi, S., Pinto, R. M., Ismail, O., Varshney, D., Lymperi, S., Sandi, C., Trabzuni, D., & Pook, M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm346 · Cited by 254
Sarg, B., Koutzamani, E., Helliger, W., Rundquist, I., & Lindner, H. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205166200 · Cited by 252
Oxidative Stress and Epigenetic Regulation in Ageing and Age-Related Diseases
Cencioni, C., Spallotta, F., Martelli, F., Valente, S., Mai, A., Zeiher, A., & Gaetano, C. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140917643 · Cited by 223
Amyotrophic lateral sclerosis in an urban setting: A population based study of inner city London
Johnston, C. A., Stanton, B. R., Turner, M. R., Gray, R., Blunt, A. H.-M., Butt, D., Ampong, M.-A., Shaw, C. E., Leigh, P. N., & Al-Chalabi, A. (2006) · Journal of Neurology · doi:10.1007/s00415-006-0195-y · Cited by 215
DNA methylation and chromatin structure: The puzzling CpG islands
Caiafa, P., & Zampieri, M. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20325 · Cited by 176
Epigenetic Variation Illustrated by DNA Methylation Patterns of the Fragile-X Gene FMR1
Stöger, R. J., Kajimura, T., Brown, W. T., & Laird, C. D. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.11.1791 · Cited by 143
Braunschweig, D., Simcox, T., Samaco, R. C., & LaSalle, J. M. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh142 · Cited by 132
Dementia and cognitive impairment in amyotrophic lateral sclerosis: a review
Giordana, M. T., Ferrero, P., Grifoni, S., Pellerino, A., Naldi, A., & Montuschi, A. (2010) · Neurological Sciences · doi:10.1007/s10072-010-0439-6 · Cited by 124
Todd, P. K., Oh, S. Y., Krans, A., Pandey, U. B., Prospero, N. A. D., Min, K., Taylor, J. P., & Paulson, H. L. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001240 · Cited by 104
Graff‐Radford, N. R., & Woodruff, B. K. (2007) · Seminars in Neurology · doi:10.1055/s-2006-956755 · Cited by 102
RNA-mediated toxicity in neurodegenerative disease
Belzil, V., Gendron, T. F., & Petrucelli, L. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.12.006 · Cited by 101
Self-citationWang, C. M., Tsai, S. N., Yew, T. W. D., Kwan, Y. W., & Ngai, S. M. (2009) · Biogerontology · doi:10.1007/s10522-009-9231-5 · Cited by 99
The involvement of the cerebellum in amyotrophic lateral sclerosis
Prell, T., & Großkreutz, J. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.812661 · Cited by 97
Renoux, A. J., & Todd, P. K. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.10.006 · Cited by 86
Laffita‐Mesa, J. M., Bauer, P. O., Kourí, V., Serrano, L. P., Roskams, J., Gotay, D. A., Brown, J. C. M., Martínez, P. A., González-Zaldívar, Y., Almaguer-Mederos, L. E., et al. (2011) · Human Genetics · doi:10.1007/s00439-011-1101-y · Cited by 52
Self-citationNasrallah, M. P., Cho, G., Simonet, J. C., Putt, M., KITAMURA, K., & Golden, J. A. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr538 · Cited by 49
Genetics and biology of Alzheimer's disease and frontotemporal lobar degeneration.
Galimberti, D., & Scarpini, E. A. (2010) · PubMed · Cited by 44
Galimberti, D., D’Addario, C., Dell’Osso, B. M., Fenoglio, C., Marcone, A., Cerami, C., Cappa, S. F., Palazzo, C., Arosio, B., Mari, D., et al. (2012) · Neurological Sciences · doi:10.1007/s10072-012-1151-5 · Cited by 42
Murgo, A. J. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.07.004 · Cited by 23
Gendron, T. F., Cosio, D. M., & Petrucelli, L. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.818659 · Cited by 16
Self-citationCan ataxin-2 be down-regulated by allele-specific de novo DNA methylation in SCA2 patients?
Bauer, P. O., Zumrová, A., Maťoška, V., Mitsui, K., & Goetz, P. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.03.046 · Cited by 9
Self-citationHuntingtin with an expanded polyglutamine repeat affects the Jab1-p27(Kip1) pathway
Cong, S., Pepers, B. A., Zhou, T., Kerkdijk, H., Roos, R. A. C., van Ommen, G. B., & Dorsman, J. C. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.03.008 · Cited by 5
Cited by
van Es, M. A., Hardiman, O., Chio, A., Al-Chalabi, A., Pasterkamp, R. J., Veldink, J. H., & van den Berg, L. H. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31287-4 · Cited by 1,298
C9orf72-mediated ALS and FTD: multiple pathways to disease
Balendra, R., & Isaacs, A. M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0047-2 · Cited by 715
C9orf72 is required for proper macrophage and microglial function in mice
O’Rourke, J. G., Bogdanik, L., Yáñez, A., Lall, D., Wolf, A. J., Muhammad, A. K. M. G., Ho, R., Carmona, S., Vit, J. P., Zarrow, J., et al. (2016) · Science · doi:10.1126/science.aaf1064 · Cited by 550
Jiang, J., Zhu, Q., Gendron, T. F., Saberi, S., McAlonis-Downes, M., Seelman, A., Stauffer, J. E., Jafar-nejad, P., Drenner, K., Schulte, D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.04.006 · Cited by 536
“, haploinsufficiency) is supported by decreased expression of C9ORF72 mRNAs in patient tissues resulting from DNA and histone hypermethylation with partial silencing of the repeat-containing allele (Belzil et al., 2013; DeJesus-Hernandez et al., 2011; Gijselinck et al., 2012; Liu et al., 2014; Xi et al., 2013, 2015).”
Self-citationRisk factors for amyotrophic lateral sclerosis
Fang, F., Ingre, C., Roos, P., Kamel, F., & Piehl, F. (2015) · Clinical Epidemiology · doi:10.2147/clep.s37505 · Cited by 462
Metadata
- Authors
- Belzil, V. V., Bauer, P. O., Prudencio, M., Gendron, T. F., Stetler, C. T., Yan, I. K., Pregent, L., Daughrity, L., Baker, M. C., Rademakers, R., Boylan, K., Patel, T. C., Dickson, D. W., & Petrucelli, L.
- Venue
- Acta Neuropathologica
- Published
- 2013-10-29
- Volume
- 126
- Issue
- 6
- Pages
- 895-905
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2045151039
- Cited by
- 314
- References
- 45
- FWCI
- 17.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.